Confronting the epidemic of hepatitis B and C

Mark A. Feitelson, Mark A Zern

Research output: Contribution to journalArticle

Abstract

With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.

Original languageEnglish (US)
Pages (from-to)140-144
Number of pages5
JournalChemistry and Industry (London)
Issue number4
StatePublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • Chemistry (miscellaneous)

Fingerprint Dive into the research topics of 'Confronting the epidemic of hepatitis B and C'. Together they form a unique fingerprint.

  • Cite this

    Feitelson, M. A., & Zern, M. A. (1999). Confronting the epidemic of hepatitis B and C. Chemistry and Industry (London), (4), 140-144.